Paper8304483
Regulation of prostaglandin endoperoxide synthase gene expression in rat mesangial cells by interleukin-1 beta.
Rzymkiewicz D and 3 others. Am J Physiol, 1994. Cited by 59 papers, by iCite.
Cite this record
ConductScience Library. Regulation of prostaglandin endoperoxide synthase gene expression in rat mesangial cells by interleukin-1 beta. Papers, record 8304483. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8304483
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclooxygenase Inhibitors | Major topic |
| Gene Expression | Major topic |
| Glomerular Mesangium | Major topic |
| Interleukin-1 | Major topic |
| Animals | |
| Cells, Cultured | |
| Cycloheximide | |
| Dexamethasone | |
| Immunohistochemistry | |
| Male | |
| RNA, Messenger | |
| Rats | |
| Rats, Sprague-Dawley | |
| Tetradecanoylphorbol Acetate |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| DK-38111 | NIDDK NIH HHS | United States | P01DK038111 | PubMed and NIH | NIH RePORTER |
| HL-20787 | NHLBI NIH HHS | United States | R01HL020787 | PubMed and NIH | NIH RePORTER |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32658905 | Simultaneous study of antioxidant activity, DNA protection and anti-inflammatory effect of Vernonia amygdalina leaves extracts. | PLoS One | 2020 | https://conductscience.org/library/papers/32658905 | PubMed |
| 27713354 | Nonsteroidal Anti-Inflammatory Drugs and the Kidney. | Pharmaceuticals (Basel) | 2010 | https://conductscience.org/library/papers/27713354 | PubMed |
| 19861503 | Glucose promotes the production of interleukine-1beta and cyclooxygenase-2 in mesangial cells via enhanced (Pro)renin receptor expression. | Endocrinology | 2009 | https://conductscience.org/library/papers/19861503 | PubMed |
| 9098660 | Cyclo-oxygenase isoenzymes. How recent findings affect thinking about nonsteroidal anti-inflammatory drugs. | Drugs | 1997 | https://conductscience.org/library/papers/9098660 | PubMed |
| 8621794 | Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells. | J Clin Invest | 1996 | https://conductscience.org/library/papers/8621794 | PubMed |
| 8566864 | Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats. | Gut | 1996 | https://conductscience.org/library/papers/8566864 | PubMed |
| 8543370 | Interleukin-1 beta induces expression of cyclooxygenase-2 mRNA in human gingival fibroblasts. | Inflammation | 1995 | https://conductscience.org/library/papers/8543370 | PubMed |
| 7527554 | Cross-talk between cyclooxygenase and nitric oxide pathways: prostaglandin E2 negatively modulates induction of nitric oxide synthase by interleukin 1. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/7527554 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8304483
GET https://conductscience.org/api/papers/v1/8304483/authors